BioCentury | Dec 26, 2019
Company News

Dec. 27 Company Quick Takes: Immunomedics, Qiagen, Eisai-Gilead, Melinta, Denovo-Rumpus

...Files for Bankruptcy” ). Denovo, Rumpus to develop DB102 for genetic disease Pediatric disease company Rumpus Therapeutics...
...Inc. Denovo Biopharma LLC Melinta Therapeutics Inc. Protein kinase B (AKT) (AKT1) (PKB) (PKBA) Protein kinase C (PKC) beta (PRKCB) Rumpus Therapeutics...
Items per page:
1 - 1 of 1
BioCentury | Dec 26, 2019
Company News

Dec. 27 Company Quick Takes: Immunomedics, Qiagen, Eisai-Gilead, Melinta, Denovo-Rumpus

...Files for Bankruptcy” ). Denovo, Rumpus to develop DB102 for genetic disease Pediatric disease company Rumpus Therapeutics...
...Inc. Denovo Biopharma LLC Melinta Therapeutics Inc. Protein kinase B (AKT) (AKT1) (PKB) (PKBA) Protein kinase C (PKC) beta (PRKCB) Rumpus Therapeutics...
Items per page:
1 - 1 of 1